Overview

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

This study will compare the rate and extent of absorption of TI Inhalation Powder in subjects with asthma and subjects with normal lung function. 24 eligible subjects will be enrolled into the treatment phase of the trial.

Phase:

Phase 1

Details

Lead Sponsor:

Mannkind Corporation

Treatments:

Albuterol
Insulin
Insulin, Globin Zinc
Methacholine Chloride